From the Publisher: Best Corporate Practices for the Biotech Industry

By Keith L. Carson

Volume 8, Issue 1 (Spring 2009)

There are some encouraging signs concerning the economy. We’ll know that things are improving when the big firms start to spin off companies. And the best deals will be those in which the new owners are the people who are closest to the products and technologies. As part of the deal, the divesting firm could retain certain rights or options for technologies, manufacturing, and marketing. They could also retain a certain amount of ownership in what would now be small innovative firms with people devoted to the technologies, and they could lease unused facilities to these firms instead of giving them away to people who would tear them down. And still better, would be if they returned to the very successful model of providing milestone payments when critical development goals were met…

Citation: Carson KL. From the Publisher: Best Corporate Practices for the Biotech Industry. BioProcess J, 2009; 8(1): 6. https://doi.org/10.12665/J81.KCarson

Posted online July 21, 2026